Luke Harris currently serves as Associate Director of Program Management and Portfolio Leadership at Relay Therapeutics, a position held since 2024. Prior to this role, Harris was Senior Manager of Program Management and Portfolio Leadership at Blueprint Medicines from 2022 to 2024. Experience also includes serving as Project Manager for Genedata Biologics at Genedata from 2020 to 2022 and holding progressively responsible roles at ImmunoGen, Inc. between 2012 and 2019. Earlier career positions include Associate II at MassBiologics and Associate I at Lantheus Medical Imaging, as well as an internship at AstraZeneca. Luke Harris holds an M.Sc. in Bioorganic and Medicinal Chemistry from Northeastern University and a B.Sc. in Chemistry from the University of Calgary.
This person is not in any teams
This person is not in any offices
Relay Therapeutics
1 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.